SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Jeff Collins to sit on the review panel for the Life Science Company Showcase Event at the North Carolina Biotechnology Center in Research Triangle Park, NC
News | 10. 15. 2008
